From Our Chief Medical Officer, Norman H. Edelman, MD

Lung cancer—the number one cancer killer in America—stands on the precipice of change. A major study has identified an early detection method that may reduce lung cancer deaths by 20 percent. Clinical trials are under way to test the safety of new therapies. Researchers are making firm progress in their excruciatingly complex work to create targeted and eventually individualized therapies for lung cancer that may one day replace the shotgun approach of chemotherapy, which can be highly toxic to the body’s normal cells.

In this issue of Promise of Research, we update you on the reality of lung cancer today—hot news in research, who is affected and the mysteries surrounding non-smokers who are diagnosed with lung cancer. You will meet a non-smoker in her early 50s living with a shocking lung cancer diagnosis, and her daughter, who is pouring her energies into American Lung Association volunteer work.

Our featured researcher is putting grant funds to work studying a protein believed to carry lung cancer cells to other parts of the body, which may impact the treatment of this deadly disease.

Lung cancer is responsible for nearly 30 percent of all cancer deaths in America—more than any other cancer. That startling reality must change—and the American Lung Association is committed to finding a cure. That work remains rooted in continued and expanded investments in research, which carries the promise to change the very human story of lung cancer.

— Norman H. Edelman, M.D.